---
title: "Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288903639.md"
description: "Bristol Myers Squibb (BMY) shares rose 1.18% to $57.27 on Friday, marking its third consecutive day of gains despite a broader market decline where the S&P 500 and Dow Jones fell. However, BMY underperformed compared to key competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories, which all posted higher percentage increases. The stock remains 8.93% below its 52-week high."
datetime: "2026-06-05T20:37:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288903639.md)
  - [en](https://longbridge.com/en/news/288903639.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288903639.md)
---

# Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) rallied 1.18% to $57.27 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.64% to 7,383.74 and Dow Jones Industrial Average falling 1.35% to 50,866.78.

This was the stock's third consecutive day of gains.

Bristol Myers Squibb Co. closed 8.93% below its 52-week high of $62.89, which the company achieved on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 2.02% to $232.77, Pfizer Inc. (PFE) rose 1.36% to $26.04, and Abbott Laboratories (ABT) rose 0.32% to $91.07.

Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-05-26 1637ET

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [NWS.US](https://longbridge.com/en/quote/NWS.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [NWSA.US](https://longbridge.com/en/quote/NWSA.US.md)
- [NWS.AU](https://longbridge.com/en/quote/NWS.AU.md)
- [NWSLV.AU](https://longbridge.com/en/quote/NWSLV.AU.md)

## Related News & Research

- [Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.00% on Jun 8: A Full Analysis](https://longbridge.com/en/news/289202504.md)
- [Bristol Myers Squibb Target of Unusually High Options Trading (NYSE:BMY)](https://longbridge.com/en/news/288476616.md)
- [Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock](https://longbridge.com/en/news/288895535.md)
- [Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?](https://longbridge.com/en/news/288679607.md)
- [Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?](https://longbridge.com/en/news/288539489.md)